Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252850
Status:
COMPLETED
Last Update Posted:
2022-11-10
First Post:
2005-11-11
Brief Title:
Safety of CERE-120 AAV2-NTN in Subjects With Idiopathic Parkinsons Disease
Sponsor:
Sangamo Therapeutics
Organization:
Sangamo Therapeutics
Organization Data
Organization:
Sangamo Therapeutics
Class:
INDUSTRY
Study ID:
CERE-120-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sangamo Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Joao Siffert Chief Medical Officer
Old Organization:
Ceregene
Collaborators
| Name | Class |
|---|---|
| Ceregene | INDUSTRY |